Emergent Biosolutions (EBS)

$9.74 +0.08 (0.83%)
Market Cap 515.37M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 4.12
Forward PE N/A
Profit Margin -18.26%
Debt to Equity Ratio 1.25
Volume 640,400
Avg Vol 941,600
Day's Range N/A - N/A
Shares Out 53.35M
Stochastic %K 72%
Beta 2.04
Analysts Sell
Price Target $13.50

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax va...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Address:
300 Professional Drive, Gaithersburg, United States
JerzeyDevil
JerzeyDevil Oct. 25 at 3:41 PM
$EBS 💪
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 1:29 PM
$EBS It do be like dat, Mr. Advisor. (ie. ain't going to $5)
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 1:17 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $EBS Current Share Price: $9.74 Contracts: $EBS January 15, 2027 $10 Calls Scale in: $2.99- $3.66 Scale out: $4.66-$5.99 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 1:17 PM
$EBS Strike that: it's other "Advisors". The "price action" ones.
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 12:22 PM
$EBS that's probably OHA.
0 · Reply
WinstonSmith33
WinstonSmith33 Oct. 25 at 4:50 AM
$EBS it's also worth noting that short borrow fee is going up again, slightly, but still...
0 · Reply
WinstonSmith33
WinstonSmith33 Oct. 25 at 4:47 AM
$EBS Actually, shorties covered around 800k shares in the last 2 weeks. Many things can be faked, but not all the time.
0 · Reply
KnuckleSandwich
KnuckleSandwich Oct. 25 at 3:57 AM
$EBS went from 9.9M to 8.6M
0 · Reply
KnuckleSandwich
KnuckleSandwich Oct. 25 at 3:55 AM
$EBS looks like the shorts covered a few shares
0 · Reply
alwayzwong
alwayzwong Oct. 24 at 10:55 PM
$EBS
0 · Reply
Latest News on EBS
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 8, 2025, 7:45 AM EDT - 17 days ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Sep 24, 2025, 4:05 PM EDT - 4 weeks ago

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Sep 19, 2025, 8:34 AM EDT - 5 weeks ago

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Sep 15, 2025, 8:35 AM EDT - 5 weeks ago

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Sep 9, 2025, 7:30 AM EDT - 6 weeks ago

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Sep 2, 2025, 7:40 AM EDT - 7 weeks ago

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Aug 29, 2025, 8:05 AM EDT - 2 months ago

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Aug 27, 2025, 8:01 AM EDT - 2 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Aug 21, 2025, 8:45 AM EDT - 2 months ago

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Aug 12, 2025, 12:46 PM EDT - 2 months ago

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:31 PM EDT - 2 months ago

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:15 PM EDT - 2 months ago

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Jul 28, 2025, 8:50 AM EDT - 3 months ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Jul 28, 2025, 8:50 AM EDT - 3 months ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 15, 2025, 7:30 AM EDT - 3 months ago

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Jul 8, 2025, 4:45 PM EDT - 3 months ago

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Jul 2, 2025, 4:05 PM EDT - 4 months ago

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 23, 2025, 8:05 AM EDT - 4 months ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 2:25 PM EDT - 4 months ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 20, 2025, 8:13 AM EDT - 4 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Jun 5, 2025, 7:00 AM EDT - 5 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:01 PM EDT - 6 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 6 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

May 1, 2025, 5:07 PM EDT - 6 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 22, 2025, 8:00 AM EDT - 6 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 7 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 4:30 PM EDT - 7 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Mar 20, 2025, 8:06 AM EDT - 7 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 19, 2025, 4:30 PM EDT - 7 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Mar 18, 2025, 8:00 AM EDT - 7 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Mar 13, 2025, 8:29 AM EDT - 8 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 10, 2025, 9:14 AM EDT - 8 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:58 PM EST - 8 months ago

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 4:23 PM EST - 8 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 8:55 AM EST - 8 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Feb 7, 2025, 8:06 AM EST - 9 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 16, 2025, 8:00 AM EST - 10 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 10 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Jan 14, 2025, 7:30 AM EST - 10 months ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Jan 13, 2025, 9:27 AM EST - 10 months ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 8, 2025, 7:45 AM EST - 10 months ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Jan 8, 2025, 7:30 AM EST - 10 months ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

Dec 2, 2024, 5:49 PM EST - 11 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

SIGA

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Nov 8, 2024, 9:25 AM EST - 1 year ago

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Nov 7, 2024, 2:06 PM EST - 1 year ago

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:08 PM EST - 1 year ago

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Nov 6, 2024, 4:49 PM EST - 1 year ago

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Nov 4, 2024, 7:30 AM EST - 1 year ago

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

JerzeyDevil
JerzeyDevil Oct. 25 at 3:41 PM
$EBS 💪
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 1:29 PM
$EBS It do be like dat, Mr. Advisor. (ie. ain't going to $5)
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 1:17 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $EBS Current Share Price: $9.74 Contracts: $EBS January 15, 2027 $10 Calls Scale in: $2.99- $3.66 Scale out: $4.66-$5.99 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 1:17 PM
$EBS Strike that: it's other "Advisors". The "price action" ones.
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 25 at 12:22 PM
$EBS that's probably OHA.
0 · Reply
WinstonSmith33
WinstonSmith33 Oct. 25 at 4:50 AM
$EBS it's also worth noting that short borrow fee is going up again, slightly, but still...
0 · Reply
WinstonSmith33
WinstonSmith33 Oct. 25 at 4:47 AM
$EBS Actually, shorties covered around 800k shares in the last 2 weeks. Many things can be faked, but not all the time.
0 · Reply
KnuckleSandwich
KnuckleSandwich Oct. 25 at 3:57 AM
$EBS went from 9.9M to 8.6M
0 · Reply
KnuckleSandwich
KnuckleSandwich Oct. 25 at 3:55 AM
$EBS looks like the shorts covered a few shares
0 · Reply
alwayzwong
alwayzwong Oct. 24 at 10:55 PM
$EBS
0 · Reply
WinningorLearning1080
WinningorLearning1080 Oct. 24 at 8:31 PM
$EBS First time since last year going into Q3 earnings that we didn't slide the week before. A solid +6% this week. Can't wait for next Wednesday!
1 · Reply
ComradeKomisar
ComradeKomisar Oct. 24 at 8:12 PM
$EBS Deep
1 · Reply
IntelligunInvestings
IntelligunInvestings Oct. 24 at 8:07 PM
$EBS looked away for like 30 mins
0 · Reply
RockDoctor
RockDoctor Oct. 24 at 6:06 PM
$EBS 10 is a Red Herring. 12 the more important line in the sand
1 · Reply
alwayzwong
alwayzwong Oct. 24 at 6:00 PM
$EBS may be the last few days that we’ll see single digits. Enjoy the sight!
0 · Reply
WinstonSmith33
WinstonSmith33 Oct. 24 at 5:59 PM
$EBS 9.99$ is a new 6.66$, but in the mirror. Obviously +0.33$ today (look at my login). Designed not by accident! Probably last days when you can see single digits. I've been saying this for some time, but how many times one can be wrong?
1 · Reply
ComradeKomisar
ComradeKomisar Oct. 24 at 5:14 PM
$EBS Powerful observation!
0 · Reply
ComradeKomisar
ComradeKomisar Oct. 24 at 5:13 PM
$EBS Remember this guy? He's surrendered, and 'eating some humble pie'. No pie for Fye yet.
1 · Reply
JerzeyDevil
JerzeyDevil Oct. 24 at 4:20 PM
$EBS 💪 Let’s barrel into the 10s!!!
0 · Reply
Cyclonerunner
Cyclonerunner Oct. 24 at 4:12 PM
$EBS just can't get over the $10 hump
2 · Reply
ComradeKomisar
ComradeKomisar Oct. 24 at 4:07 PM
$EBS
1 · Reply
telomerase
telomerase Oct. 24 at 3:45 PM
$EBS maybe it really will hit $10 this time! Congrats to the long suffering investors here. (I'm too chicken to find out, of course... GLTA
0 · Reply